We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.00 | 0.22% | 1,342.50 | 1,340.00 | 1,340.50 | 1,345.00 | 1,335.50 | 1,338.00 | 3,344,130 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.28 | 55.52B |
Date | Subject | Author | Discuss |
---|---|---|---|
27/4/2009 17:27 | Positive news on Avodart | mowy76 | |
27/4/2009 17:22 | rncaine - Was announced on CNBC 30 mins ago and the RNS has just been released to the Exchange. See link below:- | wongauk | |
27/4/2009 17:22 | REDUCE Topline Results (GlaxoSmithKline) TIDMGSK RNS Number : 2476R GlaxoSmithKline PLC 27 April 2009 Issued: Monday 27 April 2009, London UK & Philadelphia, US - LSE Announcement Large, long-term study shows dutasteride reduced prostate cancer risk in men at increased risk of the disease - Primary endpoint achieved in REDUCE study as presented at American Urological Association Headline data from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial was presented at the American Urological Association in Chicago, Illinois today. The study population was men between the ages of 50 and 75 who were at increased risk for prostate cancer with prostate specific antigen (PSA) levels between 2.5 and 10 ng/mL (men aged 50 to 60 years) and between 3.0 and 10.0 ng/mL (men aged greater than 60 years). REDUCE achieved its primary endpoint and demonstrated that dutasteride significantly reduced the risk of all biopsy-detectable prostate cancer by 23% (p | ebomber | |
27/4/2009 17:18 | i said at the weekend that i listened to glaxo's webcast and the tone of the CEO in answering a question confirmed to me the results were good. this is a potential blockbuster drug just still amazed they ever saw 881p last thursday | mjs64 | |
27/4/2009 17:18 | wonga, where have you seen this ? | rncaine | |
27/4/2009 17:14 | 1135p if the WHO ups level from Level 3 to Level 4. We will know shortly. | montyhedge | |
27/4/2009 17:13 | I say 1135p. Add 14p on price come Wed, ex div date. | montyhedge | |
27/4/2009 17:10 | Do we actually have a target price for this tommorrow..... I'm thinking this could jump to 1150p? | wongauk | |
27/4/2009 17:06 | Add another 15p on that news, when approved by FDA add 100p. | montyhedge | |
27/4/2009 17:00 | Okay, thanks. Therefore $32 is approx. the £11 breakthrough mark. Here's hoping they close at $32 tonight for a quick rise tomorrow a.m | rncaine | |
27/4/2009 16:58 | GSK just confirmed the success of Advodart drug. | wongauk | |
27/4/2009 16:56 | Divide by 2 = $15.72 divide by $1.466 exhange rate = £10.72p roughly. | montyhedge | |
27/4/2009 16:54 | monty, how do you get 31.45 to be 10.72 by dividing by 2 ? | rncaine | |
27/4/2009 16:51 | rncaine Divide by 2 = 1072p uk price. | montyhedge | |
27/4/2009 16:46 | rncaine Not sure, can anyone else inform us. | montyhedge | |
27/4/2009 16:43 | monty, whats the conversion back to GBP ? thanks | rncaine | |
27/4/2009 16:41 | GSK adr's now up 7.58% flying. | montyhedge | |
27/4/2009 16:29 | This is impossible to chart as to where the share price might go in the next 48 hours or so IMO.... but it's definitely going north lol :-) DavidHP - What is the relevance of Germany in your last post... are you thinking of the Euro? Cheers. | wongauk | |
27/4/2009 16:22 | GSK despatching to Mexican government :-0 | wongauk | |
27/4/2009 16:21 | Yanks piling in GSK adr's up over 7% at the moment in US. | montyhedge | |
27/4/2009 16:20 | Okay! Don't say I didn't warn you! Wait until the virus is detected in Germany. Expect customs officers at UK ports of entry to be asked to watch for the 'ill looking' travellers from the americas and Europe. Laugh now. Not a problem for me. Have a nice one, guys. BTW asteroid collisions are not a realistic Black Swan to plan for... it happens and the stockmarkets are the least of our worries. Realistic Black Swans are what I have been making money out of all through this disaster since Summer 2008! Never made so much. Stay away from the dollar. Have fun. DYOR | davidhp | |
27/4/2009 15:48 | Hectorp lol, GSK price just started, Level 4 to be announced later tonight GSK 1125p tomorrow. | montyhedge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions